Get the Stockscreener App
1.225
8.41%
0.095
Pmv Pharmaceuticals Inc stock is traded at $1.225, with a volume of 546.04K.
It is up +8.41% in the last 24 hours and down -12.50% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.13
Open:
$1.16
24h Volume:
546.04K
Relative Volume:
1.08
Market Cap:
$65.18M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.225
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-2.00%
1M Performance:
-12.50%
6M Performance:
+11.36%
1Y Performance:
-17.79%
1-Day Range:
$1.1102
$1.27
1-Week Range:
$1.11
$1.27
52-Week Range:
$0.81
$1.84
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.225 | 60.13M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.89 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.18 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.32 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
850.56 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.34 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
How PMV Pharmaceuticals Inc. stock responds to policy changesMarket Risk Report & Expert Verified Movement Alerts - Улправда
How strong is PMV Pharmaceuticals Inc. stock balance sheetMarket Performance Report & Weekly Top Gainers Alerts - Улправда
Will PMV Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Intraday Action & Weekly Sector Rotation Insights - Улправда
Institutions don’t gamble. Every trade is backed by:Sector ETF Performance & Access Free Risk Analysis Before You Invest - Bollywood Helpline
The Left Shoulder and Head formed clearly.Price Momentum Alerts & Outstanding Investment Trading - Bollywood Helpline
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7%Here's Why - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7% – Here’s Why - Defense World
Will PMV Pharmaceuticals Inc. stock continue upward momentumPortfolio Gains Report & Real-Time Sentiment Analysis - Newser
How PMV Pharmaceuticals Inc. stock compares to growth peers2025 Major Catalysts & AI Driven Price Predictions - moha.gov.vn
Will PMV Pharmaceuticals Inc. stock split attract more investors2025 Historical Comparison & Fast Exit/Entry Strategy Plans - BỘ NỘI VỤ
PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison - Defense World
Why PMV Pharmaceuticals Inc. stock is a must watch in 2025Trade Risk Summary & Safe Entry Zone Identification - newser.com
Why PMV Pharmaceuticals Inc. stock appeals to analysts2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
Contrasting PMV Pharmaceuticals (NASDAQ:PMVP) & Kiora Pharmaceuticals (NASDAQ:KPRX) - Defense World
Is PMV Pharmaceuticals Inc. stock poised for growth2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
How rising interest rates impact PMV Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Will PMV Pharmaceuticals Inc. stock outperform Dow Jones index2025 Price Targets & Real-Time Price Movement Reports - newser.com
Will PMV Pharmaceuticals Inc. stock benefit from commodity pricesCEO Change & Growth Oriented Trading Recommendations - newser.com
Is PMV Pharmaceuticals Inc. stock safe for conservative investorsJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Is PMV Pharmaceuticals Inc. building a consolidation base2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Top Penny Stocks To Watch In November 2025 - simplywall.st
Can PMV Pharmaceuticals Inc. stock deliver surprise earnings beat2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
HC Wainwright Issues Positive Outlook for PMVP Earnings - Defense World
Published on: 2025-11-16 01:59:30 - newser.com
Real time social sentiment graph for PMV Pharmaceuticals Inc.2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Sio Capital Management, LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
0.39%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):